HomeClinical TopicsFDA clears glucose monitoring system for use in critically ill patients.

FDA clears glucose monitoring system for use in critically ill patients.

On September 24, the U.S. Food and Drug Administration (FDA) cleared a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its use to critically ill patients who have been hospitalized. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content